Article: Study Shows Ramelteon Reduced Insomnia Symptoms in Elderly.

BOCA RATON, Fla., June 8 /PRNewswire/ --

   WHAT: Results from a Phase 3, three-way crossover study presented at the 
 National Institutes of Mental Health New Clinical Drug Evaluation 
 Unit (NCDEU) Scientific Conference on Wednesday, June 8, showed 
 that ramelteon, an investigational compound currently undergoing 
 review with the FDA for the treatment of insomnia, helped elderly 
 patients with chronic insomnia fall asleep faster and sleep longer 
 compared to placebo. 
 
 Additionally, there was no evidence of next-day residual effects 
 (i.e., recall memory, level of alertness and concentration) in 
 ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!